237 related articles for article (PubMed ID: 9620991)
1. Characterization of a nerve growth factor-inducible cellular activity that enhances herpes simplex virus type 1 gene expression and replication of an ICP0 null mutant in cells of neural lineage.
Jordan R; Pepe J; Schaffer PA
J Virol; 1998 Jul; 72(7):5373-82. PubMed ID: 9620991
[TBL] [Abstract][Full Text] [Related]
2. Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis.
Jordan R; Schaffer PA
J Virol; 1997 Sep; 71(9):6850-62. PubMed ID: 9261410
[TBL] [Abstract][Full Text] [Related]
3. ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.
Halford WP; Schaffer PA
J Virol; 2001 Apr; 75(7):3240-9. PubMed ID: 11238850
[TBL] [Abstract][Full Text] [Related]
4. An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1.
Yao F; Schaffer PA
J Virol; 1995 Oct; 69(10):6249-58. PubMed ID: 7666525
[TBL] [Abstract][Full Text] [Related]
5. The herpes simplex virus type 1 latency-associated transcript promoter is activated through Ras and Raf by nerve growth factor and sodium butyrate in PC12 cells.
Frazier DP; Cox D; Godshalk EM; Schaffer PA
J Virol; 1996 Nov; 70(11):7424-32. PubMed ID: 8892860
[TBL] [Abstract][Full Text] [Related]
6. Mutations Inactivating Herpes Simplex Virus 1 MicroRNA miR-H2 Do Not Detectably Increase ICP0 Gene Expression in Infected Cultured Cells or Mouse Trigeminal Ganglia.
Pan D; Pesola JM; Li G; McCarron S; Coen DM
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847363
[TBL] [Abstract][Full Text] [Related]
7. ICP0 is not required for efficient stress-induced reactivation of herpes simplex virus type 1 from cultured quiescently infected neuronal cells.
Miller CS; Danaher RJ; Jacob RJ
J Virol; 2006 Apr; 80(7):3360-8. PubMed ID: 16537603
[TBL] [Abstract][Full Text] [Related]
8. Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.
Thompson RL; Sawtell NM
J Virol; 2006 Nov; 80(22):10919-30. PubMed ID: 16943285
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Small-Molecule Inhibitors Targeting the E3 Ubiquitin Ligase Activity of the Herpes Simplex Virus 1 ICP0 Protein Using an
Deschamps T; Waisner H; Dogrammatzis C; Roy A; Chacko S; Perera C; Prisinzano TE; Kalamvoki M
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996104
[TBL] [Abstract][Full Text] [Related]
10. STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts.
Everett RD; Young DF; Randall RE; Orr A
J Virol; 2008 Sep; 82(17):8871-81. PubMed ID: 18579584
[TBL] [Abstract][Full Text] [Related]
11. Cellular Transcriptional Coactivator RanBP10 and Herpes Simplex Virus 1 ICP0 Interact and Synergistically Promote Viral Gene Expression and Replication.
Sato Y; Kato A; Maruzuru Y; Oyama M; Kozuka-Hata H; Arii J; Kawaguchi Y
J Virol; 2016 Jan; 90(6):3173-86. PubMed ID: 26739050
[TBL] [Abstract][Full Text] [Related]
12. The herpes simplex virus type 1 immediate-early protein ICP0 is necessary for the efficient establishment of latent infection.
Wilcox CL; Smith RL; Everett RD; Mysofski D
J Virol; 1997 Sep; 71(9):6777-85. PubMed ID: 9261402
[TBL] [Abstract][Full Text] [Related]
13. The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency.
Cai W; Astor TL; Liptak LM; Cho C; Coen DM; Schaffer PA
J Virol; 1993 Dec; 67(12):7501-12. PubMed ID: 8230470
[TBL] [Abstract][Full Text] [Related]
14. Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo.
Halford WP; Schaffer PA
J Virol; 2000 Jul; 74(13):5957-67. PubMed ID: 10846077
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells.
Cai W; Schaffer PA
J Virol; 1992 May; 66(5):2904-15. PubMed ID: 1313909
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of nerve growth factor and dexamethasone on herpes simplex virus type 1 oriL- and oriS-dependent DNA replication in PC12 cells.
Hardwicke MA; Schaffer PA
J Virol; 1997 May; 71(5):3580-7. PubMed ID: 9094630
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the herpes simplex virus type 1 ICP0 C3HC4 zinc ring finger reveals a requirement for ICP0 in the expression of the essential alpha27 gene.
Lium EK; Silverstein S
J Virol; 1997 Nov; 71(11):8602-14. PubMed ID: 9343218
[TBL] [Abstract][Full Text] [Related]
18. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta.
Härle P; Sainz B; Carr DJ; Halford WP
Virology; 2002 Feb; 293(2):295-304. PubMed ID: 11886249
[TBL] [Abstract][Full Text] [Related]
19. The replication defect of ICP0-null mutant herpes simplex virus 1 can be largely complemented by the combined activities of human cytomegalovirus proteins IE1 and pp71.
Everett RD; Bell AJ; Lu Y; Orr A
J Virol; 2013 Jan; 87(2):978-90. PubMed ID: 23135716
[TBL] [Abstract][Full Text] [Related]
20. Reactivation of expression from quiescent herpes simplex virus type 1 genomes in the absence of immediate-early protein ICP0.
Preston CM
J Virol; 2007 Nov; 81(21):11781-9. PubMed ID: 17715242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
